The purpose of this study is to evaluate the safety of LXR-623 in healthy Japanese subjects.
- Healthy, Japanese Males aged 20-45 years
- A history or active presence of clinically important medical disease
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative
Pfizer Clinical Trials Contact Center
call now email
Contact a representative by phone, email, or visiting the study website. Please see the references below: